The SIU wishes its members, colleagues and friends around the world a safe and joyous New Year!
On the heels of SIU’s B2B GU Cancer Triad Meeting, here’s an expert overview of the design, outcomes, and implications of the JAVELIN Bladder 100 trial. Watch this open-access experts’ highlights session now on SIU Academy.
Having difficulty keeping up with the rapidly evolving landscape of RCC treatment? Get the latest on recent developments across the RCC disease spectrum from B2B GUCancer Triad RCC Experts: Drs. Thomas Powles, Brian Rini and Srikala Sridhar. Open access on SIU Academy!
Get the experts’ takeaways from the November 7 B2B GU Cancers Triad Bladder Cancer session! Hear about significant clinical trial data from 2020, the role of biomarkers in response to Tx & evolving therapies for Tx of MIBC & NMIBC, and more! Click here to view on SIU Academy.
Unable to connect this weekend, or looking to re-watch a session? All B2B GU Cancer Triad sessions are available on-demand via the SIU Academy platform, for free. Watch any time at your convenience and share with friends and colleagues.
See what content was the most-viewed in October! Visit SIU Academy for all top-ten content.
Help shape SIU educational programming in 2021. Make sure that your educational needs are being met: take this short survey and share with colleagues.
